20 results
10-K
2021 FY
EX-10.7
VERV
Verve Therapeutics Inc
14 Mar 22
Annual report
7:04am
that enables us to attract and retain outstanding director candidates and reflects the substantial time commitment necessary to oversee the Company’s affairs
S-1/A
EX-10.8
VERV
Verve Therapeutics Inc
14 Jun 21
IPO registration (amended)
6:15am
the substantial time commitment necessary to oversee the Company’s affairs. We also seek to align the interests of our directors and our stockholders
S-1
EX-10.9
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
communications between the Parties and oversee, review and manage the Development and Commercialization of Opt-In Products and Collaboration Products … ’ activities under this Agreement, the JSC shall, subject to the terms of this Agreement, in particular:
oversee the collaborative activities
DRS
EX-10.10
VERV
Verve Therapeutics Inc
16 Apr 21
Draft registration statement
12:00am
communications between the Parties and oversee, review and manage the Development and Commercialization of Opt-In Products and Collaboration Products … ’ activities under this Agreement, the JSC shall, subject to the terms of this Agreement, in particular:
oversee the collaborative activities
DEF 14A
xvx6h
29 Apr 22
Definitive proxy
7:01am
DRS
EX-10.11
3spjew 8q
16 Apr 21
Draft registration statement
12:00am
S-1
EX-10.10
nbe3ov 1w2x4ia386
28 May 21
IPO registration
4:04pm
S-1
wk08g
28 May 21
IPO registration
4:04pm
10-K
g29mum yirj2v
14 Mar 22
Annual report
7:04am
424B4
5iu sbfgpwb88
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
sfgxh2mbrhqwqaj4s
14 Jun 21
IPO registration (amended)
6:15am
DRS
6chbs
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next